Almanac 2013: acute coronary syndromes

Area of Science:

• Cardiology
• Vascular Biology

Background:

• Unstable coronary artery plaque is the primary cause of acute coronary syndromes (ACS).
• ACS encompasses conditions like unstable angina, non-ST segment elevation myocardial infarction (NSTE-ACS), and ST-elevation myocardial infarction (STEMI).
• Ischaemia-induced tachyarrhythmias can lead to sudden cardiac arrest.

Purpose of the Study:

• To review the underlying causes and manifestations of acute coronary syndromes.
• To highlight the declining mortality rates associated with ACS.
• To discuss the impact of novel antiplatelet agents on ACS outcomes.

Main Methods:

• Literature review of recent therapeutic advancements in ACS management.
• Analysis of trends in ACS mortality.
• Discussion of emerging antiplatelet medications.

Main Results:

• Mortality rates for ACS, particularly STEMI and cardiac arrest, have significantly decreased.
• Novel antiplatelet agents, including prasugrel, ticagrelor, and cangrelor, are contributing to improved patient outcomes.
• Therapeutic progress is expected to further reduce ACS-related mortality.

Conclusions:

• Unstable plaque remains a critical factor in ACS.
• Advancements in antiplatelet therapy represent a significant step forward in managing ACS.
• Continued progress in treatment is anticipated to further improve survival rates for ACS patients.